The novel α-Gal-based immunotherapy AGI-134 invokes CD8+T cell-mediated immunity by driving tumor cell destruction, phagocytosis and tumor-associated antigen cross-presentation via multiple antibody-mediated effector functions

被引：1
|
作者：
Middleton, Jenny L.
Schulz, Oliver
Charlemagne, Amber
Kristian, Sascha A.
Shaw, Stephen Michael
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-616
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
616
引用
收藏
页数：2
相关论文
共 3 条
  • [1] EGC enhances tumor antigen presentation and CD8+T cell-mediated antitumor immunity via targeting oncoprotein SND1
    Zhang, Xinxin
    Cui, Xiaoteng
    Li, Peiying
    Zhao, Yan
    Ren, Yuanyuan
    Zhang, Heng
    Zhang, Shijie
    Li, Chufeng
    Wang, Xinting
    Shi, Lei
    Sun, Tao
    Hao, Jihui
    Yao, Zhi
    Chen, Jun
    Gao, Xingjie
    Yang, Jie
    CANCER LETTERS, 2024, 592
  • [2] Monoclonal antibodies targeted against melanoma and ovarian tumors enhance dendritic cell-mediated cross-presentation of tumor-associated antigens and efficiently cross-prime CD8+ T cells
    Cioca, DP
    Deak, E
    Cioca, F
    Paunescu, V
    JOURNAL OF IMMUNOTHERAPY, 2006, 29 (01) : 41 - 52
  • [3] Tumor-associated embryonic antigen-expressing vaccines that target CCR6 elicit potent CD8+ T cell-mediated protective and therapeutic antitumor immunity
    Biragyn, Arya
    Schiavo, Roberta
    Olkhanud, Purevdorj
    Sumitomo, Kenya
    King, Alan
    McCain, Megan
    Indig, Fred E.
    Almanzar, Giovanni
    Baatar, Dolgor
    JOURNAL OF IMMUNOLOGY, 2007, 179 (02): : 1381 - 1388
1